These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10332167)
21. The management of hypertrophic cardiomyopathy. Spirito P; Seidman CE; McKenna WJ; Maron BJ N Engl J Med; 1997 Mar; 336(11):775-85. PubMed ID: 9052657 [No Abstract] [Full Text] [Related]
22. Left Ventricular Outflow Obstruction After TAVR Due to Systolic Anterior Motion Successfully Treated With Cardiac Pacing. Marchel M; Szczerba E; Pędzich-Placha E; Huczek Z; Kochman J; Kochanowski J; Grabowski M; Opolski G J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2718-2721. PubMed ID: 32624430 [No Abstract] [Full Text] [Related]
23. Dual-chamber pacing in hypertrophic obstructive cardiomyopathy with biventricular outflow tract obstruction and severe drug-refractory symptoms in a 9-year-old girl. Ohtani K; Satoh A; Eto S; Satoh T; Ichinose K; Satoh S; Takahashi T; Koda M; Kinjo M; Yonesaka S Pediatr Int; 2003 Dec; 45(6):743-6. PubMed ID: 14651555 [No Abstract] [Full Text] [Related]
24. Contemporary treatment of hypertrophic cardiomyopathy. Marian AJ Tex Heart Inst J; 2009; 36(3):194-204. PubMed ID: 19568388 [No Abstract] [Full Text] [Related]
25. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy. Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. ten Berg JM; van Tooren R; Jaarsma W; Suttorp MJ; Plokker HW J Am Coll Cardiol; 1998 Nov; 32(5):1485. PubMed ID: 9809970 [No Abstract] [Full Text] [Related]
27. A case of hypertrophic cardiomyopathy with mid-ventricular obstruction (MVO) -- dramatic long-term improvement with a DDD pacemaker as assessed by diastolic paradoxical jet flow velocity. Sasaki Y; Inoue T; Beppu H; Shirasawa K; Kida Y; Takeda S; Ayukawa H; Shirasaka A; Kakio T; Doi T; Hashimoto T; Kawai C Int J Cardiol; 2011 Jul; 150(2):217-9. PubMed ID: 21663981 [No Abstract] [Full Text] [Related]
28. Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality echocardiographic techniques. Luckie M; Khattar RS Minerva Cardioangiol; 2011 Dec; 59(6):581-9. PubMed ID: 22134470 [TBL] [Abstract][Full Text] [Related]
29. Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant. Boriani G; Rapezzi C; Biffi M; Branzi A Int J Cardiol; 2002 May; 83(2):171-3. PubMed ID: 12007691 [No Abstract] [Full Text] [Related]
33. Hypertrophic cardiomyopathy: from bedside to bench...and now back again? Ommen SR; Tajik AJ Circulation; 2001 Jul; 104(2):126-7. PubMed ID: 11447071 [No Abstract] [Full Text] [Related]
34. Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male. Magage S; Linhart A; Bultas J; Vojacek J; Mates M; Palecek T; Popelová J; Tintera J; Aschermann M; Goldman ME; Desnick RJ Echocardiography; 2005 Apr; 22(4):333-9. PubMed ID: 15839990 [TBL] [Abstract][Full Text] [Related]
35. Triple type of obstruction in hypertrophic cardiomyopathy. Efthimiadis GK; Parcharidou DG; Vassilikos V; Giannakoulas G; Pliakos C; Parcharidis GE J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1156-8. PubMed ID: 18852593 [No Abstract] [Full Text] [Related]
36. Managing hypertension in the elderly. Cheng TO Lancet; 1992 Jan; 339(8787):252. PubMed ID: 1346214 [No Abstract] [Full Text] [Related]
37. How far do we want to go in the treatment of obstruction in Hypertrophic Cardiomyopathy? Pastor A; Petrillo F; Navarro M; González-Carrillo J; de la Morena G Int J Cardiol; 2015 Sep; 195():95-7. PubMed ID: 26025866 [No Abstract] [Full Text] [Related]
38. Antihypertensive therapy in hypertrophic cardiomyopathy. Argulian E; Messerli FH; Aziz EF; Winson G; Agarwal V; Kaddaha F; Kim B; Sherrid MV Am J Cardiol; 2013 Apr; 111(7):1040-5. PubMed ID: 23340036 [TBL] [Abstract][Full Text] [Related]
39. Are there sex differences following treatment of left ventricular outflow tract obstruction in adults with hypertrophic cardiomyopathy? Chahal AA; Alhurani RE; Mohamed EA; Somers VK; Miller VM; Murad MH; Ahmed AT Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):249-250. PubMed ID: 28838090 [No Abstract] [Full Text] [Related]
40. Surgical correction of hypertrophic obstructive cardiomyopathy in patients with simultaneous obstruction of left ventricular midcavity and right ventricular outflow tract. Borisov KV Eur J Cardiothorac Surg; 2013 Jan; 43(1):67-72. PubMed ID: 22529188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]